CITCO

CITCO

中文名称CITCO
中文同义词6-(4-氯苯基)咪唑并[2,1-B]噻唑-5-甲醛 O-(3,4-二氯苄基)肟;化合物CITCO;化合物CITCO,10 MM DMSO 溶液
英文名称CITCO
英文同义词Imidazo[2,1-b]thiazole-5-carboxaldehyde, 6-(4-chlorophenyl)-, O-[(3,4-dichlorophenyl)methyl]oxime;6-(4-Chlorophenyl)imidazo[2,1-b]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl) oxime;CITCO,Inhibitor,inhibit,Apoptosis;CITCO, 10 mM in DMSO
CAS号338404-52-7
分子式C19H12Cl3N3OS
分子量436.74
EINECS号
相关类别
Mol文件338404-52-7.mol
结构式CITCO 结构式

CITCO 性质

密度1.48±0.1 g/cm3(Predicted)
储存条件-20°C
溶解度DMSO:28 mg/mL,可溶
形态固体
酸度系数(pKa)4.05±0.40(Predicted)
颜色浅黄至黄色
InChI1S/C19H12Cl3N3OS/c20-14-4-2-13(3-5-14)18-17(25-7-8-27-19(25)24-18)10-23-26-11-12-1-6-15(21)16(22)9-12/h1-10H,11H2/b23-10+
InChIKeyZQWBOKJVVYNKTL-AUEPDCJTSA-N
SMILESClc1ccc(cc1)-c2nc3sccn3c2\C=N\OCc4ccc(Cl)c(Cl)c4

CITCO 用途与合成方法

CITCO 是一种组成型雄甾烷 (Constitutive androstane) 受体激动剂,抑制脑肿瘤干细胞 (BTSCs) 的生长和扩增。CITCO 是一种咪唑并噻唑衍生物,其作为人 CAR 的选择性激动剂起作用。CITCO 对于孕烷 X 受体 (PXR) 的 EC50 为 49 nM,并且对其他核受体没有活性。

CAR, PXR

CITCO (1-50 μM; 48 hours) results in a dose-dependent inhibition of viable cell count and proliferation in both T98G and U87MG glioma and BTSCs.
CITCO (2.5, 5 μM; 48 hours) induces cell cycle arrest differentially in different BTSCs in culture, but not in normal astrocytes.
CITCO (2.5-10 μM; 48 hours) induces apoptosis in BTSCs in culture in dose dependently, but not in normal astrocytes.
CITCO (0-25 μM; 48 hours) causes the T98G and U87MG glioma and BTSCs expressing very low levels of CAR protein that increased significantly.

Cell Proliferation Assay

Cell Line: T98G, U87MG, DB29 and DB33 human glioma cells, astrocytes
Concentration: 1, 2.5, 5, 10, 25, 50 μM
Incubation Time: 48 hours
Result: Resulted in a dose-dependent inhibition of viable cell count and proliferation.

Cell Cycle Analysis

Cell Line: The T98G, U87MG, DB29 and DB33 glioma cells
Concentration: 2.5, 5 μM
Incubation Time: 48 hours
Result: Induced cell cycle arrest differentially in different BTSCs in culture.

Apoptosis Analysis

Cell Line: The T98G, U87MG, DB29 and DB33 glioma cells
Concentration: 2.5, 5 or 10 μM
Incubation Time: 48 hours
Result: Increased the levels of Annexin V-positive apoptotic cells in dose dependently.

Western Blot Analysis

Cell Line: T98G, U87MG, DB29 and DB33 glioma cells
Concentration: 0 to 25 μM
Incubation Time: 48 hours
Result: The T98G, U87MG glioma and BTSCs expressed very low levels of CAR protein that increased significantly.

CITCO (intraperitoneal; on days 22, 24, 26, 30 and 36) with 25 μg results a significant decrease in tumour growth, which further decreases to an undetectable level after treatment with 100 μg CITCO .

Animal Model: Six- to eight-week-old male athymic nude mice
Dosage: 25 or 100 μg
Administration: Intraperitoneal; on days 22, 24, 26, 30 and 36
Result: Decreased tumour growth.

安全信息

危险品标志Xi
危险类别码36/37/38
安全说明26-36
WGK Germany3
存储类别11 - 可燃固体
危险性类别眼部刺激 类别2
经皮刺激 类别2
特异性靶器官毒性-一次接触,类别3

MSDS信息

更新日期产品编号产品名称CAS号包装价格
2026/09/15HY-103244CITCO
CITCO
338404-52-71 mg335元
2026/09/15HY-103244CITCO
CITCO
338404-52-75 mg700元

CITCO 上下游产品信息

"CITCO"相关产品信息
3-(3-吲哚基)-2-氧代丙酸 4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯胺 橙黄决明素 化合物Z-CITCO 盐酸多柔比星
主页 | 企业会员服务 | 广告业务 | 联系我们 | 旧版入口 | 中文MSDS | CAS Index | 常用化学品CAS列表 | 化工产品目录 | 新产品列表 | 评选活动 | HS海关编码 | MSDS查询 | 化工站点

Copyright © 2016-2023 ChemicalBook 版权所有  京ICP备07040585号  京公海网安备11010802032676号  

互联网增值电信业务经营许可证:京ICP证150597号  (京)网药械信息备字(2025)第00155号  信息系统安全等级保护备案证明(三级)  营业执照公示

本网站展示的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
根据相关法律法规和本站规定,单位或个人购买相关危险物品应取得有效的资质、资格条件。

参考《应急管理部等多部门关于加强互联网销售危险化学品安全管理的通知 (应急〔2022〕119号)》和《互联网危险物品信息发布管理规定》